A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Redmond, founder and CEO of Dr. Stephanie’s Supplements, showcased her products, which she described as the latest innovations in supplement options for hormone and metabolic health, including a ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

Boosting Bacteroides vulgatus in diabetic mice increased GLP-1 secretion, improving blood sugar control and reducing sugar ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

The following content is for informational purposes only. This article is not intended to be a substitute for profession ...

Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...

Researchers have discovered gut bacteria that may naturally suppress hunger, offering a potential alternative to drugs like Ozempic, Wegovy and Rybelsus.

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.